Latest 8-K filings

ACCESS Newswire Inc. reported stable Q2 2026 revenue of $5.6M, with average ARR per customer increasing to $12,718, though Adjusted EBITDA decreased to $642,000.

Lincoln Electric Holdings, Inc. announced the resignation of Michael J. Whitehead, Executive Vice President and President of Americas Welding, effective August 28, 2026.

Regions Financial Corporation announced key executive leadership changes, including the upcoming retirement of Chief Administrative Officer David R. Keenan and the appointments of Katherine R. Danella and John T. Jordan to new senior roles.

Surf Air Mobility Inc. announced the satisfaction of closing conditions for its previously disclosed Secured Purchase Agreement, leading to the issuance of the remaining $14 million in Senior Secured Debentures, bringing the total to $21.6 million.

Stabilis Solutions, Inc. reported the results of its Annual Meeting, confirming the election of its director nominees and the ratification of its independent registered public accounting firm.

SolarMax Technology, Inc. is implementing a 1-for-12 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement.

Wheeler Real Estate Investment Trust, Inc. announced the issuance of common stock in exchange for preferred stock, retiring the preferred shares without cash proceeds.

AIM ImmunoTech CEO Thomas K. Equels published an article in Breaking Defense discussing the potential of Ampligen as a broad-spectrum antiviral for biodefense applications, including Ebola and coronaviruses.

Syra Health announced robust financial results for Q2 2026, showcasing a 23% revenue increase and sustained profitability.

Apollo Global Management, Inc. subsidiary Athene Holding Ltd. has released a presentation detailing its corporate structure, accessible on its investor relations website.

Athene Holding Ltd. has released a presentation detailing its corporate structure, available on its investor relations website.

Idaho Copper Corporation announces the appointment of four independent directors and the formation of key board committees, enhancing its governance structure ahead of its NYSE American listing.

KIDZ AI Inc. is implementing a 1-for-15 reverse stock split to boost its share price and meet Nasdaq's minimum bid requirement, effective August 13, 2026.

Adagio Medical Holdings announced second quarter 2026 financial results, highlighting progress in its vCLAS Ultra catheter and FULCRUM-VT trial, alongside an increased net loss.

PDS Biotechnology Corporation announced a strategic refocus on its PDS0301 program for metastatic colorectal cancer and will seek partnerships for PDS0101, discontinuing its Phase 3 trial.

Ultragenyx Pharmaceutical Inc. has reached a settlement agreement resolving patent litigation concerning its DOJOLVI oral liquid with Esjay Pharma.

WEC Energy Group, Inc. announced the appointment of Caroline Garcia as Vice President and Controller, effective August 31, 2026, succeeding William J. Guc who will transition to a special advisor role.

Energy Focus, Inc. announced its second quarter 2026 financial results, reporting a substantial increase in net sales driven by commercial and military segments, but also a significant widening of net loss and negative gross profit margins.

Mereo BioPharma announced Q2 2026 results, highlighting a significant option and license agreement for alvelestat with Sentynl Therapeutics and an extended cash runway into late 2027.

Veradermics announces positive Phase 2 results for VDPHL01 in female hair loss, completes enrollment for a key Phase 2/3 trial, and reports a strong cash position extending operational runway to 2030.

TON Strategy Company announced robust second quarter 2026 financial results, highlighted by a significant increase in staking revenue and substantial reductions in operating costs.

Enviri Corporation announced its second quarter 2026 results, reporting a GAAP consolidated loss of $297 million, largely due to charges from exiting Harsco Rail ETO contracts and other restructuring costs, though Adjusted EBITDA showed improvement.

Theriva Biologics announced second quarter 2026 financial results and provided updates on its VCN-01 clinical programs, including patient dosing in the VIRAGE2 Phase 2a study for metastatic pancreatic cancer.

Butterfly Network, Inc. announces the resignation of Dr. Erica Schwartz from its Board of Directors, effective August 5, 2026, following her confirmation as Director of the Centers for Disease Control and Prevention.

Mereo BioPharma Group plc has entered into an option and license agreement with Sentynl Therapeutics, Inc. for the U.S. commercial and global manufacturing rights to alvelestat for alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Adamas Trust, Inc. announced an 11.1% increase in its quarterly common stock dividend to $0.30 per share, reflecting confidence in its financial position and outlook.

ManpowerGroup Inc. announced the appointment of John B. Gibson, Jr., President and CEO of Paychex, Inc., to its Board of Directors, effective September 1, 2026.

LB Pharmaceuticals announced accelerated topline data for its LB-102 schizophrenia trial, plans pipeline expansion, and secured $150 million in funding.

Protara Therapeutics announced its second quarter 2026 financial results, highlighting progress in its clinical trials for TARA-002 and IV Choline Chloride, with a cash runway extending into 2028.

Kalaris Therapeutics announced second quarter 2026 financial results, reporting $93.5 million in cash and ongoing patient dosing in its Phase 1b/2 study for TH103, with preliminary data anticipated in 1H 2027.